Archive for February, 2011

LZR merges, MSFT moving, CRME skips a beat

Monday, February 7th, 2011

Emergent Group Inc. (AMEX: LZR) shares sprang up 38.8 per cent to $8.41, on volume of 284,325 or more than 11 times its daily average. Monday, it was announced that LZR was to be acquired by Universal Hospital Services for $8.46 a share.

Microsoft Inc. (Nasdaq: MSFT) traded in 25.3 million shares, pursuing a daily average of 58.4 million. Share prices added 1.6 percent to $28.22, amid general momentum in the tech world.

Cardiome Pharma Corporation (Nasdaq: CRME) lost 11.4 percent Monday to $6.06. Volume was 561,971 shares, nearly twice its normal daily average. Vancouver-based CRME is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system.

PDE proud, SIRI loud, ONAV down

Monday, February 7th, 2011

Pride International Inc. (NYSE: PDE) shares rose 16.2 per cent to $39.98, on volume of 15.5 million, thumping its two-million-share daily average, on news that the offshore oil driller will be acquired by Ensco PLC (NYSE: ESV) in a cash-and-stock deal worth $41.60 a share. Ensco shares slid 3.8 percent to $52.35.

Sirius XM Radio Inc. (Nasdaq: SIRI) was active Monday, trading in 18.6 million shares, catching up on a daily average of 52.1 million. Share prices added 1.7 percent to $1.79.

Omega Navigation Enterprises Inc. (Nasdaq: ONAV) lost 6.2 percent Monday to $1.06. Volume was 221,053 shares, nearly four times its normal daily average. ONAV is a provider of global marine transportation services focusing on product tankers.

BEC gets bought, C sells, DEAR dives

Monday, February 7th, 2011

Beckman Coulter Inc. (NYSE: BEC) shares gained 9.7 percent to $82.49, on volume of nearly 27 million shares, towering over its average of 1.3 million, after industrial company Danaher Corp. (NYSE: DHR) said it would buy the medical-diagnostics firm in a deal valued at about $6.8 billion. Danaher shares traveled higher 3.5 percent to $49.68.

Citigroup Inc. (NYSE: C) was busy on the markets Monday, trading in 75 million shares, catching up on a daily average of 561 million. Share prices added 0.9 percent to $4.86. C announced that its Global Transaction Services has launched a new module within its TreasuryVision® portal that simplifies how companies manage internal lending relationships between their legal entities.

Dearborn Bancorp Inc. (Nasdaq: DEAR) lost 11 percent Monday to $1.54. Volume for the stock was 165,420 shares, leading its normal daily average of 116,091, after reporting Friday a quarterly loss of $2.4 million, still less than half its loss in the prior-year quarter.

EL up, PFE active, FBN floored

Thursday, February 3rd, 2011

Estee Lauder Cos. (NYSE: EL) shares gained 14.8 percent to $92.49, on volume of 4.9 million – or quadruple its daily average, after the cosmetics maker raised its fiscal-year forecast.

Pfizer Inc. (NYSE: PFE) was busy on the markets Thursday, trading in 52.5 million shares, beating out its daily average of 47 million. Share prices marched again 1.4 percent to $19.22, although biotechs in general were flat to downward Thursday.

Furniture Brands International (NYSE: FBN) lost 17.7 percent of its price strength Thursday to $3.78. Volume for the stock was 4.9 million shares, or more than 12 times its normal daily average, after reporting Thursday a net Q4 loss of $44.7 million, still an improvement from the quarterly loss of $65 million it suffered a year earlier.

CELL rings, INTC trades widely, ICGN takes breather

Thursday, February 3rd, 2011

Brightpoint Inc. (Nasdaq: CELL) shares moved north 32 percent Thursday to $12.57, on volumes of nearly three million, six times its full-day average, a day after presenting Q4 earnings that beat Street estimates.

Intel Inc. (Nasdaq: INTC) traded in 27.3 million shares Thursday, trailing its all-day average of 55.5 million. Shares for the chipmaker nosed ahead 0.6 percent to $21.50.

Icagen Inc. (Nasdaq: ICGN) got thumped 12.6 percent in price to $3.25 Thursday. Volume was 809,218, besting its daily average of 563,036, after the FDA lifted its hold on ICGN’s epilepsy drug.